Is Proton Beam Therapy Cost Effective in the Treatment of Adenocarcinoma of the Prostate?

Overview of attention for article published in Journal of Clinical Oncology, August 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

policy: 4 policy sources
twitter: 3 X users
wikipedia: 1 Wikipedia page

reddit: 1 Redditor
guideline: 2 clinical guideline sources

Readers on

mendeley: 110 Mendeley

So far, Altmetric has seen 5 policy documents that reference this research output.

Sorafenib for treating advanced hepatocellular carcinoma: Committee papers Company submissions - TA189 ACD1 06 May 2009

Cited by National Institute for Health and Care Excellence (NICE) on 31 Aug 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen: Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): evaluation report

Cited by National Institute for Health and Care Excellence (NICE) on 18 Oct 2013

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Recent developments in medical techniques involving ionising or nonionising radiation

Cited by Rijksinstituut voor Volksgezondheid en Milieu on 23 Jan 2012

RIVM works to prevent and control outbreaks of infectious diseases. We promote public health and consumer safety, and we help to protect the quality of the environment.

Rapport Protonentherapie

Cited by Zorginstituut Nederland on 03 Sep 2009

Zorginstituut Nederland (Netherlands Healthcare Institute) is an independent Dutch administrative body that ensures that Dutch citizens are and remain insured in accordance with the Health Insurance Act and the Long-Term Care Act. The Healthcare Institute occupies an independent position between the Ministry of Health, Welfare and Sport, health insurers, care providers and patient organizations.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity, including 1 additional policy documents.